A

Alkermes plc

ALKS

26.860
USD
-0.44
(-1.61%)
مغلق
حجم التداول
68,208
الربح لكل سهم
0
العائد الربحي
0
P/E
12
حجم السوق
4,630,473,411
أصول ذات صلة
A
ALB
-0.490
(-0.52%)
93.150 USD
A
ALGN
-3.810
(-1.64%)
228.270 USD
A
ALK
-1.190
(-3.17%)
36.330 USD
A
ALNY
31.19
(13.13%)
268.66 USD
A
ALSN
-1.354
(-1.53%)
87.230 USD
A
ALX
-8.460
(-3.48%)
234.500 USD
الأخبار المقالات

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.